Macular Ganglion Cell–Inner Plexiform Layer: Automated Detection and Thickness Reproducibility with Spectral Domain–Optical Coherence Tomography in Glaucoma

To demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in glaucomatous eyes. Fifty-one glaucomatous eyes (26 mild, 11 moderate, 14 severe) of 51 patients underwent macular scanning using the Cirrus HD...

Full description

Saved in:
Bibliographic Details
Published inInvestigative ophthalmology & visual science Vol. 52; no. 11; pp. 8323 - 8329
Main Authors Mwanza, Jean-Claude, Oakley, Jonathan D., Budenz, Donald L., Chang, Robert T., Knight, O'Rese J., Feuer, William J.
Format Journal Article
LanguageEnglish
Published United States Association for Research in Vision and Ophthalmology, Inc 21.10.2011
Subjects
Online AccessGet full text
ISSN1552-5783
0146-0404
1552-5783
DOI10.1167/iovs.11-7962

Cover

Abstract To demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in glaucomatous eyes. Fifty-one glaucomatous eyes (26 mild, 11 moderate, 14 severe) of 51 patients underwent macular scanning using the Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) macula 200×200 acquisition protocol. Five scans were obtained on 5 days within 2 months. The ganglion cell analysis (GCA) algorithm was used to detect the macular GCIPL and to measure the thickness of the overall average, minimum, superotemporal, superior, superonasal, inferonasal, inferior, and inferotemporal GCIPL. The reproducibility of the measurements was evaluated with intraclass correlation coefficients (ICCs), coefficients of variation (COVs), and test-retest standard deviations (TRTSDs). Segmentation and measurement of GCIPL thickness were successful in 50 of 51 subjects. All ICCs ranged between 0.94 and 0.98, but ICCs for average and superior GCIPL parameters (0.97-0.98) were slightly higher than for inferior GCIPL parameters (0.94-0.97). All COVs were <5%, with 1.8% for average GCIPL and COVs for superior GCIPL parameters (2.2%-3.0%) slightly lower than those for inferior GCIPL parameters (2.5%-3.6%). The TRTSD was lowest for average GCIPL (1.16 μm) and varied from 1.43 to 2.15 μm for sectoral GCIPL CONCLUSIONS: The Cirrus HD-OCT GCA algorithm can successfully segment macular GCIPL and measure GCIPL thickness with excellent intervisit reproducibility. Longitudinal monitoring of GCIPL thickness may be possible with Cirrus HD-OCT for assessing glaucoma progression.
AbstractList To demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in glaucomatous eyes. Fifty-one glaucomatous eyes (26 mild, 11 moderate, 14 severe) of 51 patients underwent macular scanning using the Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) macula 200×200 acquisition protocol. Five scans were obtained on 5 days within 2 months. The ganglion cell analysis (GCA) algorithm was used to detect the macular GCIPL and to measure the thickness of the overall average, minimum, superotemporal, superior, superonasal, inferonasal, inferior, and inferotemporal GCIPL. The reproducibility of the measurements was evaluated with intraclass correlation coefficients (ICCs), coefficients of variation (COVs), and test-retest standard deviations (TRTSDs). Segmentation and measurement of GCIPL thickness were successful in 50 of 51 subjects. All ICCs ranged between 0.94 and 0.98, but ICCs for average and superior GCIPL parameters (0.97-0.98) were slightly higher than for inferior GCIPL parameters (0.94-0.97). All COVs were <5%, with 1.8% for average GCIPL and COVs for superior GCIPL parameters (2.2%-3.0%) slightly lower than those for inferior GCIPL parameters (2.5%-3.6%). The TRTSD was lowest for average GCIPL (1.16 μm) and varied from 1.43 to 2.15 μm for sectoral GCIPL CONCLUSIONS: The Cirrus HD-OCT GCA algorithm can successfully segment macular GCIPL and measure GCIPL thickness with excellent intervisit reproducibility. Longitudinal monitoring of GCIPL thickness may be possible with Cirrus HD-OCT for assessing glaucoma progression.
To demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in glaucomatous eyes.PURPOSETo demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in glaucomatous eyes.Fifty-one glaucomatous eyes (26 mild, 11 moderate, 14 severe) of 51 patients underwent macular scanning using the Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) macula 200×200 acquisition protocol. Five scans were obtained on 5 days within 2 months. The ganglion cell analysis (GCA) algorithm was used to detect the macular GCIPL and to measure the thickness of the overall average, minimum, superotemporal, superior, superonasal, inferonasal, inferior, and inferotemporal GCIPL. The reproducibility of the measurements was evaluated with intraclass correlation coefficients (ICCs), coefficients of variation (COVs), and test-retest standard deviations (TRTSDs).METHODSFifty-one glaucomatous eyes (26 mild, 11 moderate, 14 severe) of 51 patients underwent macular scanning using the Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) macula 200×200 acquisition protocol. Five scans were obtained on 5 days within 2 months. The ganglion cell analysis (GCA) algorithm was used to detect the macular GCIPL and to measure the thickness of the overall average, minimum, superotemporal, superior, superonasal, inferonasal, inferior, and inferotemporal GCIPL. The reproducibility of the measurements was evaluated with intraclass correlation coefficients (ICCs), coefficients of variation (COVs), and test-retest standard deviations (TRTSDs).Segmentation and measurement of GCIPL thickness were successful in 50 of 51 subjects. All ICCs ranged between 0.94 and 0.98, but ICCs for average and superior GCIPL parameters (0.97-0.98) were slightly higher than for inferior GCIPL parameters (0.94-0.97). All COVs were <5%, with 1.8% for average GCIPL and COVs for superior GCIPL parameters (2.2%-3.0%) slightly lower than those for inferior GCIPL parameters (2.5%-3.6%). The TRTSD was lowest for average GCIPL (1.16 μm) and varied from 1.43 to 2.15 μm for sectoral GCIPL CONCLUSIONS: The Cirrus HD-OCT GCA algorithm can successfully segment macular GCIPL and measure GCIPL thickness with excellent intervisit reproducibility. Longitudinal monitoring of GCIPL thickness may be possible with Cirrus HD-OCT for assessing glaucoma progression.RESULTSSegmentation and measurement of GCIPL thickness were successful in 50 of 51 subjects. All ICCs ranged between 0.94 and 0.98, but ICCs for average and superior GCIPL parameters (0.97-0.98) were slightly higher than for inferior GCIPL parameters (0.94-0.97). All COVs were <5%, with 1.8% for average GCIPL and COVs for superior GCIPL parameters (2.2%-3.0%) slightly lower than those for inferior GCIPL parameters (2.5%-3.6%). The TRTSD was lowest for average GCIPL (1.16 μm) and varied from 1.43 to 2.15 μm for sectoral GCIPL CONCLUSIONS: The Cirrus HD-OCT GCA algorithm can successfully segment macular GCIPL and measure GCIPL thickness with excellent intervisit reproducibility. Longitudinal monitoring of GCIPL thickness may be possible with Cirrus HD-OCT for assessing glaucoma progression.
The retinal ganglion cell–inner plexiform layer, which is known to get thinner with worsening glaucoma, can be measured with excellent reproducibility using spectral domain–optical coherence tomography. This may prove useful in following up patients for glaucoma progression.
Author Budenz, Donald L.
Oakley, Jonathan D.
Feuer, William J.
Knight, O'Rese J.
Chang, Robert T.
Mwanza, Jean-Claude
Author_xml – sequence: 1
  givenname: Jean-Claude
  surname: Mwanza
  fullname: Mwanza, Jean-Claude
  organization: From the Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida; and
– sequence: 2
  givenname: Jonathan D.
  surname: Oakley
  fullname: Oakley, Jonathan D.
  organization: Voxeleron, LLC, Pleasanton, California
– sequence: 3
  givenname: Donald L.
  surname: Budenz
  fullname: Budenz, Donald L.
  organization: From the Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida; and
– sequence: 4
  givenname: Robert T.
  surname: Chang
  fullname: Chang, Robert T.
  organization: From the Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida; and
– sequence: 5
  givenname: O'Rese J.
  surname: Knight
  fullname: Knight, O'Rese J.
  organization: From the Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida; and
– sequence: 6
  givenname: William J.
  surname: Feuer
  fullname: Feuer, William J.
  organization: From the Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida; and
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21917932$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1v1DAQjVAR_YAbZ-QbFwJ2vIkTDkjVFpZKi4pgOVsTZ3ZjcOzUTlpy4z_wB_ht_BIcbakKEhwsP43fm-d5c5wcWGcxSR4z-pyxQrzQ7ipElIqqyO4lRyzPszQXJT-4gw-T4xA-U5oxltEHyWHGKiYqnh0lP96BGg14sgK7M9pZskRjfn77fm4tevLe4Fe9db4ja5jQvySn4-A6GLAhZzigGmYF2IZsWq2-WAyBfMDeu2ZUutZGDxO51kNLPvaR68GQs6jWNva_6AetYmHpWvRoFZKN69zOQ99ORFuyMjCqSH6Y3N-CCfjo5j5JPr15vVm-TdcXq_Pl6TpVvORDKkSJtFoIyMt4agZlvi2hEnmNOQrKm6IUJUUlKCxEFZNAseCZ4DWwiDnlJ0m67zvaHqZrMEb2XnfgJ8monJOWc9IRyTnpyH-15_dj3WGj0M7z3WocaPnni9Wt3LkryTNassVs-PSmgXeXI4ZBdjqoGD5YdGOQ8ZMFL3g2Wz25a3Xr8XuLkZDtCcq7EDxupdIDzLuJztr8a4Bnf4n-O-8vkCjFjg
CitedBy_id crossref_primary_10_1186_s12886_020_01601_y
crossref_primary_10_1155_2015_605940
crossref_primary_10_3109_15569527_2014_975240
crossref_primary_10_1016_j_xops_2023_100353
crossref_primary_10_1016_j_ophtha_2014_09_031
crossref_primary_10_1097_ICU_0000000000000231
crossref_primary_10_1177_1120672119894887
crossref_primary_10_3389_fnagi_2021_666495
crossref_primary_10_1016_j_ajo_2014_10_032
crossref_primary_10_3341_kjo_2021_0131
crossref_primary_10_1007_s10384_023_01009_3
crossref_primary_10_5005_jp_journals_10028_1238
crossref_primary_10_1016_j_ophtha_2017_03_014
crossref_primary_10_1097_IJG_0000000000000994
crossref_primary_10_1167_iovs_18_25910
crossref_primary_10_1097_WNO_0000000000001569
crossref_primary_10_1371_journal_pone_0141293
crossref_primary_10_1007_s10384_014_0355_z
crossref_primary_10_1155_2016_2394957
crossref_primary_10_1167_tvst_11_8_12
crossref_primary_10_1016_j_ajo_2017_07_007
crossref_primary_10_1016_j_ajo_2022_11_004
crossref_primary_10_1097_APO_0b013e3182747e4c
crossref_primary_10_1016_j_jfo_2013_08_002
crossref_primary_10_1089_pho_2013_3693
crossref_primary_10_3390_diagnostics13020266
crossref_primary_10_1016_j_ophtha_2018_08_009
crossref_primary_10_1371_journal_pone_0147964
crossref_primary_10_1097_WNO_0000000000000240
crossref_primary_10_3389_fopht_2023_1217125
crossref_primary_10_1001_jamanetworkopen_2023_13220
crossref_primary_10_1136_bjophthalmol_2015_307326
crossref_primary_10_1177_2515841419899819
crossref_primary_10_1007_s10384_014_0327_3
crossref_primary_10_1167_tvst_13_4_3
crossref_primary_10_1007_s00417_014_2706_3
crossref_primary_10_1371_journal_pone_0130175
crossref_primary_10_1016_j_ajo_2018_05_029
crossref_primary_10_3341_kjo_2014_28_4_314
crossref_primary_10_1016_j_ajo_2017_03_019
crossref_primary_10_1136_bmjophth_2020_000595
crossref_primary_10_1007_s00417_013_2494_1
crossref_primary_10_1007_s10384_022_00970_9
crossref_primary_10_1631_jzus_B1900506
crossref_primary_10_1007_s10792_017_0635_y
crossref_primary_10_1167_iovs_63_9_16
crossref_primary_10_1177_2515841419899822
crossref_primary_10_1093_gerona_glaa135
crossref_primary_10_1167_iovs_64_15_8
crossref_primary_10_1097_IJG_0000000000002157
crossref_primary_10_1097_IJG_0000000000002399
crossref_primary_10_1007_s10384_013_0241_0
crossref_primary_10_1016_j_msard_2019_101387
crossref_primary_10_1080_02713683_2018_1530360
crossref_primary_10_1136_bjophthalmol_2017_310959
crossref_primary_10_1136_bjophthalmol_2012_302242
crossref_primary_10_1364_BOE_8_000579
crossref_primary_10_1016_j_jfo_2013_01_005
crossref_primary_10_1111_aos_12485
crossref_primary_10_1016_j_ophtha_2014_02_019
crossref_primary_10_1007_s00417_013_2529_7
crossref_primary_10_1016_j_ajo_2021_05_016
crossref_primary_10_12677_ACM_2022_123222
crossref_primary_10_1016_j_ophtha_2014_02_010
crossref_primary_10_1136_bjophthalmol_2018_313159
crossref_primary_10_1016_j_ajo_2017_03_008
crossref_primary_10_1111_ceo_12724
crossref_primary_10_2147_OPTH_S369807
crossref_primary_10_1016_j_ajo_2021_05_012
crossref_primary_10_1371_journal_pone_0196112
crossref_primary_10_1371_journal_pone_0155319
crossref_primary_10_3390_ijms17111894
crossref_primary_10_1097_WNO_0000000000000345
crossref_primary_10_1371_journal_pone_0206684
crossref_primary_10_62347_EHTP6496
crossref_primary_10_1136_bjophthalmol_2013_303185
crossref_primary_10_1038_s41598_021_85010_1
crossref_primary_10_1097_IJG_0000000000000889
crossref_primary_10_1016_j_ogla_2022_06_008
crossref_primary_10_1007_s10384_013_0258_4
crossref_primary_10_1097_IJG_0000000000001928
crossref_primary_10_4103_ijo_IJO_2086_20
crossref_primary_10_1016_j_ophtha_2018_03_052
crossref_primary_10_1111_ceo_14471
crossref_primary_10_18231_j_ijceo_2023_106
crossref_primary_10_1016_j_jfo_2021_11_010
crossref_primary_10_3341_jkos_2015_56_4_485
crossref_primary_10_1097_MD_0000000000021680
crossref_primary_10_1371_journal_pone_0160448
crossref_primary_10_3341_jkos_2014_55_8_1167
crossref_primary_10_1186_s40662_018_0101_6
crossref_primary_10_1371_journal_pone_0232785
crossref_primary_10_1097_IJG_0000000000001125
crossref_primary_10_1097_OPX_0000000000001347
crossref_primary_10_1371_journal_pone_0187093
crossref_primary_10_1364_BOE_504637
crossref_primary_10_1111_aos_14884
crossref_primary_10_1167_tvst_9_8_40
crossref_primary_10_1007_s10633_022_09900_z
crossref_primary_10_1136_bjophthalmol_2018_312162
crossref_primary_10_1097_MD_0000000000006855
crossref_primary_10_1186_1471_2415_14_132
crossref_primary_10_1007_s00417_014_2697_0
crossref_primary_10_1159_000362177
crossref_primary_10_1007_s10792_022_02569_y
crossref_primary_10_1136_bjophthalmol_2014_306538
crossref_primary_10_1038_s41598_020_63486_7
crossref_primary_10_1097_IJG_0000000000000709
crossref_primary_10_4103_ijo_IJO_1955_18
crossref_primary_10_1016_j_ajo_2014_05_034
crossref_primary_10_1167_tvst_10_3_28
crossref_primary_10_2174_1874364101509010078
crossref_primary_10_1016_j_oftal_2013_03_002
crossref_primary_10_1371_journal_pone_0159583
crossref_primary_10_1038_s41598_021_88832_1
crossref_primary_10_1038_s41433_020_0847_7
crossref_primary_10_1097_IJG_0000000000001598
crossref_primary_10_1136_bjophthalmol_2020_317756
crossref_primary_10_1155_2014_468908
crossref_primary_10_1016_j_ajo_2016_08_021
crossref_primary_10_1097_IJG_0000000000000028
crossref_primary_10_1080_02713683_2018_1518460
crossref_primary_10_1177_11206721211073216
crossref_primary_10_1364_BOE_516045
crossref_primary_10_1155_2017_6078365
crossref_primary_10_1016_j_ophtha_2020_01_055
crossref_primary_10_1097_WCO_0000000000000897
crossref_primary_10_2147_EB_S337333
crossref_primary_10_3341_kjo_2018_0030
crossref_primary_10_1097_OPX_0000000000000392
crossref_primary_10_1155_2013_821460
crossref_primary_10_1016_j_ophtha_2014_04_030
crossref_primary_10_1038_s41598_017_07714_7
crossref_primary_10_1016_j_sjopt_2015_02_007
crossref_primary_10_1371_journal_pone_0160549
crossref_primary_10_1167_iovs_18_24083
crossref_primary_10_1155_2015_460918
crossref_primary_10_1155_2016_8307639
crossref_primary_10_1371_journal_pone_0210729
crossref_primary_10_1016_j_ajo_2019_04_034
crossref_primary_10_1016_j_jfo_2015_03_015
crossref_primary_10_1097_MD_0000000000005785
crossref_primary_10_1155_joph_8824342
crossref_primary_10_1167_tvst_8_5_27
crossref_primary_10_1371_journal_pone_0137316
crossref_primary_10_1186_s12886_016_0216_2
crossref_primary_10_1016_j_ogla_2020_08_002
crossref_primary_10_1177_1120672120947593
crossref_primary_10_1016_j_ajo_2017_09_010
crossref_primary_10_1111_aos_12438
crossref_primary_10_3109_02713683_2014_956371
crossref_primary_10_1080_17469899_2016_1229599
crossref_primary_10_1097_IAE_0000000000001036
crossref_primary_10_1097_IJG_0000000000000285
crossref_primary_10_1155_2017_8923819
crossref_primary_10_1371_journal_pone_0174377
crossref_primary_10_1097_IJG_0000000000002104
crossref_primary_10_1097_IJG_0000000000000168
crossref_primary_10_1111_aos_14291
crossref_primary_10_4068_cmj_2016_52_3_194
crossref_primary_10_1212_WNL_0000000000001046
crossref_primary_10_1007_s00417_013_2557_3
crossref_primary_10_1136_bjophthalmol_2013_303660
crossref_primary_10_1007_s40135_013_0014_4
crossref_primary_10_3928_23258160_20151008_05
crossref_primary_10_1016_j_pnpbp_2019_109825
crossref_primary_10_1111_aos_12666
crossref_primary_10_1186_s12886_023_03145_3
crossref_primary_10_1364_BOE_7_002888
crossref_primary_10_1177_1352458514523498
crossref_primary_10_3109_08820538_2012_712734
crossref_primary_10_1007_s10792_015_0157_4
crossref_primary_10_1371_journal_pone_0150035
crossref_primary_10_1016_j_pdpdt_2021_102335
crossref_primary_10_1038_eye_2015_86
crossref_primary_10_1136_bjophthalmol_2014_305259
crossref_primary_10_1007_s10633_022_09869_9
crossref_primary_10_1371_journal_pone_0184064
crossref_primary_10_5318_wjo_v5_i2_86
crossref_primary_10_1016_j_ophtha_2013_10_044
crossref_primary_10_1186_s40942_017_0078_7
crossref_primary_10_5005_jp_journals_10008_1108
crossref_primary_10_1016_j_ajo_2015_05_015
crossref_primary_10_1098_rspb_2018_2733
crossref_primary_10_1016_j_ajo_2014_07_029
crossref_primary_10_1038_s41598_020_70852_y
crossref_primary_10_1016_j_ophtha_2013_05_031
crossref_primary_10_1136_bjophthalmol_2014_305361
crossref_primary_10_1097_ICU_0b013e32835d9e27
crossref_primary_10_1177_1120672118795062
crossref_primary_10_3390_jcm10184231
crossref_primary_10_1097_OPX_0000000000001251
crossref_primary_10_4103_joco_joco_270_23
crossref_primary_10_1016_j_ogla_2021_01_003
crossref_primary_10_1007_s00417_013_2344_1
crossref_primary_10_1007_s00417_022_05619_4
crossref_primary_10_1016_j_ophtha_2013_06_041
crossref_primary_10_1038_s41551_021_00813_x
crossref_primary_10_3928_15428877_20121003_01
crossref_primary_10_1016_j_msard_2022_103745
crossref_primary_10_1080_02713683_2019_1567792
crossref_primary_10_1016_j_ophtha_2020_06_067
crossref_primary_10_1097_OPX_0b013e31824f164d
crossref_primary_10_1016_j_xops_2021_100055
crossref_primary_10_1371_journal_pone_0128925
crossref_primary_10_1155_2016_9785939
crossref_primary_10_1186_s40478_024_01732_z
crossref_primary_10_1016_j_ajo_2015_10_007
crossref_primary_10_3389_fneur_2017_00359
crossref_primary_10_1016_j_pdpdt_2022_103125
crossref_primary_10_1016_j_survophthal_2020_03_002
crossref_primary_10_1038_s41433_024_03191_1
crossref_primary_10_31083_j_jin2301023
crossref_primary_10_3389_fneur_2018_00321
crossref_primary_10_1097_IJG_0000000000000814
crossref_primary_10_1016_j_ajo_2013_06_029
crossref_primary_10_1016_j_preteyeres_2016_12_002
crossref_primary_10_1080_08820538_2021_1922711
crossref_primary_10_1016_j_ogla_2022_03_001
crossref_primary_10_3341_jkos_2021_62_3_362
crossref_primary_10_17116_oftalma2023139011122
crossref_primary_10_1371_journal_pone_0151000
crossref_primary_10_1371_journal_pone_0106117
crossref_primary_10_1111_opo_12643
crossref_primary_10_1097_IAE_0000000000002323
crossref_primary_10_1155_2017_4673714
crossref_primary_10_1016_j_ajo_2015_09_019
crossref_primary_10_3109_02713683_2013_807932
crossref_primary_10_1016_j_ajo_2014_08_040
crossref_primary_10_3341_kjo_2020_0013
crossref_primary_10_1097_IJG_0b013e31827b155b
crossref_primary_10_1136_bjophthalmol_2018_312349
crossref_primary_10_1016_j_clinph_2018_10_007
crossref_primary_10_1002_epi4_13004
crossref_primary_10_1007_s00417_018_3944_6
crossref_primary_10_1159_000510572
crossref_primary_10_1007_s10384_018_0593_6
crossref_primary_10_1016_j_jfo_2023_01_008
crossref_primary_10_1111_cxo_12585
crossref_primary_10_3390_jcm9103294
crossref_primary_10_5301_ejo_5001067
crossref_primary_10_1371_journal_pone_0248284
crossref_primary_10_1007_s00417_017_3710_1
crossref_primary_10_1371_journal_pone_0263959
crossref_primary_10_3109_01658107_2015_1136654
crossref_primary_10_1016_j_ajo_2020_02_008
crossref_primary_10_1097_IAE_0000000000001631
crossref_primary_10_4103_ijo_IJO_965_20
crossref_primary_10_1167_iovs_62_1_5
crossref_primary_10_1038_eye_2016_277
crossref_primary_10_1016_j_oftale_2013_09_022
crossref_primary_10_3389_fopht_2024_1497848
crossref_primary_10_1016_j_ophtha_2011_12_014
crossref_primary_10_1038_eye_2016_13
crossref_primary_10_1016_j_ajo_2017_06_005
crossref_primary_10_1159_000530904
crossref_primary_10_1038_s41598_020_57583_w
crossref_primary_10_1038_s41598_019_39948_y
crossref_primary_10_1016_j_yaoo_2021_04_002
crossref_primary_10_3928_23258160_20180628_09
crossref_primary_10_1186_s40035_021_00230_9
crossref_primary_10_1038_s41598_020_60277_y
crossref_primary_10_4103_JOCO_JOCO_83_20
crossref_primary_10_1167_tvst_11_6_27
crossref_primary_10_1016_j_ajo_2013_08_001
crossref_primary_10_1097_IJG_0000000000000787
crossref_primary_10_4103_equest_equest_4_23
crossref_primary_10_1136_bjophthalmol_2013_304349
crossref_primary_10_4103_ijo_IJO_1755_18
crossref_primary_10_1016_j_ogla_2020_01_001
crossref_primary_10_1097_IJG_0b013e318285fd95
crossref_primary_10_1167_iovs_18_26300
crossref_primary_10_1186_s12886_017_0434_2
crossref_primary_10_1007_s10072_020_04992_4
crossref_primary_10_1016_j_ophtha_2014_06_047
crossref_primary_10_1186_s13195_024_01627_0
crossref_primary_10_1371_journal_pone_0122347
crossref_primary_10_1111_ceo_12237
crossref_primary_10_1371_journal_pone_0199134
crossref_primary_10_4103_IJO_IJO_697_23
crossref_primary_10_1097_IAE_0000000000001535
crossref_primary_10_1177_1120672120947614
crossref_primary_10_1016_j_neuroimage_2018_04_004
crossref_primary_10_1007_s10384_024_01049_3
crossref_primary_10_1016_j_ophtha_2015_07_013
crossref_primary_10_1097_IJG_0000000000000572
crossref_primary_10_1097_IJG_0000000000000210
crossref_primary_10_1097_IJG_0000000000000336
crossref_primary_10_1097_IJG_0000000000001305
crossref_primary_10_1097_IJG_0000000000000576
crossref_primary_10_1097_JCMA_0000000000000254
crossref_primary_10_1136_bjophthalmol_2014_305745
crossref_primary_10_1038_s41598_019_52354_8
crossref_primary_10_1371_journal_pone_0127906
crossref_primary_10_1038_s41598_018_28821_z
crossref_primary_10_1007_s00417_016_3408_9
crossref_primary_10_1136_bjophthalmol_2017_310869
crossref_primary_10_3341_jkos_2018_59_10_938
crossref_primary_10_5005_jp_journals_10078_1365
crossref_primary_10_1097_IJG_0000000000000683
crossref_primary_10_1097_IJG_0000000000000689
crossref_primary_10_3390_jcm12155091
crossref_primary_10_1016_j_ajo_2021_04_021
ContentType Journal Article
Copyright Copyright © Association for Research in Vision and Ophthalmology 2011
Copyright_xml – notice: Copyright © Association for Research in Vision and Ophthalmology 2011
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTOC
UNPAY
DOI 10.1167/iovs.11-7962
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1552-5783
EndPage 8329
ExternalDocumentID 10.1167/iovs.11-7962
PMC3208140
21917932
10_1167_iovs_11_7962
Genre Validation Studies
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NEI NIH HHS
  grantid: P30 EY014801
– fundername: National Institutes of Health
  grantid: P30 EY014801
GroupedDBID ---
18M
2WC
34G
39C
5GY
5RE
AAYXX
ACGFO
ACNCT
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GROUPED_DOAJ
GX1
N9A
OK1
P2P
RPM
SJN
TR2
TRV
W8F
WH7
WOQ
WOW
AFOSN
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
.55
.GJ
53G
ADTOC
AFFNX
AI.
UNPAY
VH1
X7M
ZGI
ZXP
ID FETCH-LOGICAL-c383t-778e0947a587a5b1a85f8a975be5e703d68780ec70a479002e743273ba102e303
IEDL.DBID UNPAY
ISSN 1552-5783
0146-0404
IngestDate Sun Oct 26 04:07:16 EDT 2025
Thu Aug 21 13:38:16 EDT 2025
Fri Sep 05 08:51:20 EDT 2025
Thu Apr 03 06:55:50 EDT 2025
Thu Apr 24 23:03:21 EDT 2025
Wed Oct 01 03:33:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c383t-778e0947a587a5b1a85f8a975be5e703d68780ec70a479002e743273ba102e303
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
Present affiliations: 3Department of Ophthalmology, Stanford University, Palo Alto, California; and
Department of Ophthalmology, Case Western University, Cleveland, Ohio.
OpenAccessLink https://proxy.k.utb.cz/login?url=https://iovs.arvojournals.org/arvo/content_public/journal/iovs/933458/z7g01111008323.pdf
PMID 21917932
PQID 900636322
PQPubID 23479
PageCount 7
ParticipantIDs unpaywall_primary_10_1167_iovs_11_7962
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3208140
proquest_miscellaneous_900636322
pubmed_primary_21917932
crossref_citationtrail_10_1167_iovs_11_7962
crossref_primary_10_1167_iovs_11_7962
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-Oct-21
PublicationDateYYYYMMDD 2011-10-21
PublicationDate_xml – month: 10
  year: 2011
  text: 2011-Oct-21
  day: 21
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Investigative ophthalmology & visual science
PublicationTitleAlternate Invest Ophthalmol Vis Sci
PublicationYear 2011
Publisher Association for Research in Vision and Ophthalmology, Inc
Publisher_xml – name: Association for Research in Vision and Ophthalmology, Inc
References 8550316 - Invest Ophthalmol Vis Sci. 1996 Jan;37(1):125-41
15289130 - Am J Ophthalmol. 2004 Aug;138(2):218-25
12390129 - Acta Ophthalmol Scand Suppl. 2002;236:34-6
18707672 - Am J Ophthalmol. 2008 Nov;146(5):679-87
12523883 - Arch Ophthalmol. 2003 Jan;121(1):41-6
15914617 - Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2012-7
8795733 - J Glaucoma. 1996 Feb;5(1):46-53
21052550 - J Ophthalmol. 2011;2011:914250
20940837 - Opt Express. 2010 Aug 30;18(18):19413-28
12511364 - Ophthalmology. 2003 Jan;110(1):177-89
20052083 - Opt Express. 2009 Dec 21;17(26):23719-28
9479279 - Ophthalmology. 1998 Feb;105(2):224-31
19597108 - Arch Ophthalmol. 2009 Jul;127(7):875-81
17981334 - Ophthalmology. 2008 Jun;115(6):949-56
20059261 - J Biomed Opt. 2009 Nov-Dec;14(6):064023
19744726 - Ophthalmology. 2009 Dec;116(12):2305-14.e1-2
19834029 - Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1446-52
18815101 - IEEE Trans Med Imaging. 2008 Oct;27(10):1495-505
1843453 - Ophthalmology. 1991 Jul;98(7):1128-34
20435603 - Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4646-51
19278927 - IEEE Trans Med Imaging. 2009 Sep;28(9):1436-47
20639959 - Opt Express. 2010 Jul 5;18(14):14730-44
19724565 - Opt Express. 2009 Aug 31;17(18):15659-69
20363675 - IEEE Trans Med Imaging. 2010 Jun;29(6):1321-30
20426167 - Med Image Comput Comput Assist Interv. 2009;12(Pt 2):649-56
16899526 - Br J Ophthalmol. 2006 Nov;90(11):1393-7
2229487 - J Comp Neurol. 1990 Oct 1;300(1):5-25
References_xml – reference: 21052550 - J Ophthalmol. 2011;2011:914250
– reference: 8795733 - J Glaucoma. 1996 Feb;5(1):46-53
– reference: 19724565 - Opt Express. 2009 Aug 31;17(18):15659-69
– reference: 19744726 - Ophthalmology. 2009 Dec;116(12):2305-14.e1-2
– reference: 19834029 - Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1446-52
– reference: 19278927 - IEEE Trans Med Imaging. 2009 Sep;28(9):1436-47
– reference: 19597108 - Arch Ophthalmol. 2009 Jul;127(7):875-81
– reference: 16899526 - Br J Ophthalmol. 2006 Nov;90(11):1393-7
– reference: 20940837 - Opt Express. 2010 Aug 30;18(18):19413-28
– reference: 15289130 - Am J Ophthalmol. 2004 Aug;138(2):218-25
– reference: 15914617 - Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2012-7
– reference: 1843453 - Ophthalmology. 1991 Jul;98(7):1128-34
– reference: 20435603 - Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4646-51
– reference: 12523883 - Arch Ophthalmol. 2003 Jan;121(1):41-6
– reference: 8550316 - Invest Ophthalmol Vis Sci. 1996 Jan;37(1):125-41
– reference: 20426167 - Med Image Comput Comput Assist Interv. 2009;12(Pt 2):649-56
– reference: 20059261 - J Biomed Opt. 2009 Nov-Dec;14(6):064023
– reference: 18815101 - IEEE Trans Med Imaging. 2008 Oct;27(10):1495-505
– reference: 9479279 - Ophthalmology. 1998 Feb;105(2):224-31
– reference: 12511364 - Ophthalmology. 2003 Jan;110(1):177-89
– reference: 12390129 - Acta Ophthalmol Scand Suppl. 2002;236:34-6
– reference: 18707672 - Am J Ophthalmol. 2008 Nov;146(5):679-87
– reference: 20363675 - IEEE Trans Med Imaging. 2010 Jun;29(6):1321-30
– reference: 17981334 - Ophthalmology. 2008 Jun;115(6):949-56
– reference: 2229487 - J Comp Neurol. 1990 Oct 1;300(1):5-25
– reference: 20639959 - Opt Express. 2010 Jul 5;18(14):14730-44
– reference: 20052083 - Opt Express. 2009 Dec 21;17(26):23719-28
SSID ssj0021120
Score 2.5392249
Snippet To demonstrate the capability of SD-OCT to measure macular retinal ganglion cell-inner plexiform layer (GCIPL) thickness and to assess its reproducibility in...
The retinal ganglion cell–inner plexiform layer, which is known to get thinner with worsening glaucoma, can be measured with excellent reproducibility using...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 8323
SubjectTerms Aged
Aged, 80 and over
Algorithms
Disease Progression
Glaucoma - pathology
Humans
Linear Models
Macula Lutea - pathology
Middle Aged
Reproducibility of Results
Retinal Ganglion Cells - pathology
Severity of Illness Index
Software
Tomography, Optical Coherence - methods
Tomography, Optical Coherence - standards
Title Macular Ganglion Cell–Inner Plexiform Layer: Automated Detection and Thickness Reproducibility with Spectral Domain–Optical Coherence Tomography in Glaucoma
URI https://www.ncbi.nlm.nih.gov/pubmed/21917932
https://www.proquest.com/docview/900636322
https://pubmed.ncbi.nlm.nih.gov/PMC3208140
https://iovs.arvojournals.org/arvo/content_public/journal/iovs/933458/z7g01111008323.pdf
UnpaywallVersion publishedVersion
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1552-5783
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0021120
  issn: 1552-5783
  databaseCode: DIK
  dateStart: 19620101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1552-5783
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0021120
  issn: 1552-5783
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1552-5783
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0021120
  issn: 1552-5783
  databaseCode: RPM
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VVAIu_EPNT7UH4IKc2I69u-YWtfQHSKlEIoWTtV5vaFR3HTV2UXriHXgBno0nYWbtWIQKxIWDJcseW-v17O732TPfEPJcRVnowboLIy3gbugHyo1Fxlwl-yJMfZVKmyg8PGIH4_DtJJpskEmbC1NcLLry_KJounJRawXDgR7GbmPl2Vr_udcY2Ct6QMvDSPQu-WesnY6CNf0ASGI2vUY2WQQovUM2x0fHg091RCOQ6NBWFkQBMhectr-KiWe8boLvuzxmwfpqdQWCXo2kvFGZuVx-kXn-yzK1d5ssVw9YR6ecdqsy7arL37Qf_0cP3CG3GmxLB7Uz3iUb2twj14fN3_v75PtQ2qhXui8xebgwdEfn-Y-v3w6x_hc9Rm1OxND0vQQi8JoOqrIAQK0zuqtLGzJmqDQZHZ3M1ClO0RTog1WsrUN8lxS_KtOPmDwK3UR34eqZgft_mNsv9hRzUWx2Ix0VZ41WN50Zup_LCkaefEDGe29GOwduUyHCVcCsS6AGQgM_5TISsKW-FNFUyJhHqY40zGUZE1x4WnFPhjyGyV8DYALAlkrAVRpW74ekYwqjtwjV4JdaQKd5Ghipp9JoOgUsFQI8ZF5fMIe8WnlCohr5dKzikSeWRjGe4GuAvQT9xiEvWut5LRvyBzu6cqoExjX-rJFGF9UiiRE8MphuHfKo9rH2RgFybMDdDuFr3tcaoGT4-hkzO7HS4fB4KHHmkJetn_61fY__1fAJuRk00ZGB_5R0yvNKPwO4VqbbQFQO32034-8n5H5Hng
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB6VVAIu_BfMn_YAXJAT27G9G25RS1sQKZVIpHCy1usNjWrWUWMXpSfegRfg2XgSZtaORahAXDhYsuyxtV7P7n6fPfMNwDMVZaGH6y6OtIC7oR8odyCy2FWyL8LUV6m0icKjo_hwEr6dRtMtmLa5MMX5sivPzoumK5e1VjAe6FHsNlWerfWfe42BvaKHtDyMRO-Cf6La6SRY0w-QJGazK7AdR4jSO7A9OToefqwjGpFEh7ayIAmQuei0_XVMfMzrJvi-ywdxsLlaXYKglyMpr1VmIVdfZJ7_skzt34TV-gHr6JTTblWmXXXxm_bj_-iBW3CjwbZsWDvjbdjS5g5cHTV_7-_C95G0Ua_sQFLycGHYrs7zH1-_vaH6X-yYtDkJQ7N3EonAKzasygIBtc7Yni5tyJhh0mRsfDJXpzRFM6QPVrG2DvFdMfqqzD5Q8ih2E9vDq-cG7_9-Yb_YM8pFsdmNbFx8brS62dywg1xWOPLkPZjsvx7vHrpNhQhXIbMukRoIjfyUy0jglvpSRDMhBzxKdaRxLstiwYWnFfdkyAc4-WsETAjYUom4SuPqvQMdUxj9AJhGv9QCO83TyEg9lUazGWKpEOFh7PVF7MDLtSckqpFPpyoeeWJpVMwTeg24l5DfOPC8tV7UsiF_sGNrp0pwXNPPGml0US2TAYHHGKdbB-7XPtbeKCCOjbjbAb7hfa0BSYZvnjHzEysdjo9HEmcOvGj99K_te_ivho_getBERwb-Y-iUZ5V-gnCtTJ82I-8nPIBGpQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Macular+ganglion+cell-inner+plexiform+layer%3A+automated+detection+and+thickness+reproducibility+with+spectral+domain-optical+coherence+tomography+in+glaucoma&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Mwanza%2C+Jean-Claude&rft.au=Oakley%2C+Jonathan+D&rft.au=Budenz%2C+Donald+L&rft.au=Chang%2C+Robert+T&rft.date=2011-10-21&rft.eissn=1552-5783&rft.volume=52&rft.issue=11&rft.spage=8323&rft_id=info:doi/10.1167%2Fiovs.11-7962&rft_id=info%3Apmid%2F21917932&rft.externalDocID=21917932
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon